PHARMACEUTICAL COMPOSITIONS

The present invention provides for a pharmaceutical composition that includes tetrabenazine and a release-retarding agent; and a method of treating a hyperkinetic movement disorder (e.g., Huntington's disease, chorea associated with Huntington's disease, hemiballismus, senile chorea, tic d...

Full description

Saved in:
Bibliographic Details
Main Authors LAI, JOHN CK, DUFFIELD, ANDREW JOHN, ERADIRI, OKPONANABOFA, FRISBEE, STEVEN E, JACKSON, GRAHAM
Format Patent
LanguageEnglish
French
Published 17.02.2011
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides for a pharmaceutical composition that includes tetrabenazine and a release-retarding agent; and a method of treating a hyperkinetic movement disorder (e.g., Huntington's disease, chorea associated with Huntington's disease, hemiballismus, senile chorea, tic disorders, tardive dyskinesia, myoclonus, dystonia and/or Tourette's syndrome). The method includes administering an effective amount of the pharmaceutical composition, for a period of time effective to treat the hyperkinetic movement disorder. La présente invention concerne une composition pharmaceutique contenant de la tétrabénazine et un agent ralentissant sa libération ; ainsi qu'une méthode de traitement d'une hyperkinésie (par exemple de type maladie de Huntington, chorée associée à la maladie de Huntington, hémiballisme, chorée sénile, tics, dyskinésie tardive, myoclonie, dystonie et/ou maladie de Gilles de la Tourette). Ladite méthode comprend l'administration d'une quantité efficace de ladite composition pharmaceutique, pendant une durée suffisante pour traiter ladite hyperkinésie.
Bibliography:Application Number: WO2010US45375